Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country

Microbial Drug Resistance

Volumn 17, Issue 3, 2011, Pages 395-406

  Christiansen, Nina ^a   Nielsen, Lene ^b   Jakobsen, Lotte ^a   Stegger, Marc ^a   Hansen, Lars Hestbjerg ^c   Frimodt Møller, Niels ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE ACETYLTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; APRAMYCIN; CEFOTAXIME; CEFTIOFUR; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; FLORFENICOL; GENTAMICIN; KANAMYCIN; MOXIFLOXACIN; NALIDIXIC ACID; NEOMYCIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; DENMARK; DISK DIFFUSION; DRUG MECHANISM; DRUG TRANSPORT; DRUG USE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DENMARK; DNA TOPOISOMERASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; POINT MUTATION; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 80052222316     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0015     Document Type: Article

References (60)

1. AB BIODISK 2008-08. Etest Technical Manual. Available at www.abbiodisk.com/pdf/etm-html/03-etm.htm, accessed 6 January 2011. (Online.)
2. Adachi, T., M. Mizuuchi, E.A. Robinson, E. Appella, M.H. O'Dea, M. Gellert, and K. Mizuuchi. 1987. DNA sequence of the E. coli gyrB gene: Application for a new sequencing strategy. Nucleic Acids Res. 15:771-784. (Pubitemid 17234004)
3. Bagel, S., V. Hüllen,, B. Wiedemann, and P. Heisig. 1999. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob. Agents Chemother. 43:868-875. (Pubitemid 29165751)
4. Bagger-Skjødt, L., D. Sandvang, N. Frimodt-Møller, C.H. Lester, K.E.P. Olsen, L.J. Porsbo, D.L. Monnet, and A.M. Hammerum. 2007. Association between antimicrobial resistance and virulence genes in Escherichia coli obtained from blood and faeces. Scand. J. Infect. Dis. 39:724-727. (Pubitemid 47180475)
5. Barnard, F., and A. Maxwell. 2001. Interaction between DNA gyrase and quinolones: Effects of alanine mutations at GyrA subunit residues Ser83 and Asp87. Antimicrob. Agents Chemother. 45:1994-2000. (Pubitemid 32591689)
6. Blattner, F.R., G. Plunkett, C.A. Bloch, N.T. Perna, V. Burland, M. Riley, J. Collado-Vides, J.D. Glasner, C.K. Rode, G.F. Mayhew, J. Gregor, N.W. Davis, H.A. Kirkpatrick, M.A. Goeden, D.J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli. K-12. Science 277:1453-1474.
7. Bohnert, J.A., and W.V. Kern. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849-852. (Pubitemid 40175716)
8. Cagnacci, S., L. Gualco, E. Debbia, G.C. Schito, and A. Marchese. 2008. European emergence of ciprofloxacinresistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
9. Cattoir, V., L. Poirel, V. Rotimi, C. Soussy, and P. Nordmann. 2007.Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 60:394-397. (Pubitemid 47243891)
10. Cavaco, L.M., N. Frimodt-Møller, H. Hasman, L. Guardabassi, L. Nielsen, and F.M. Aarestrup. 2008. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb. Drug Resist. 14:163-169.
11. Cavaco, L.M., H. Hasman, S. Xia, and F.M. Aarestrup. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica Serovar Kentucky and bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53:603-608.
12. [CLSI] Clinical and Laboratory Standards Institute. 2008. Document, table 2A: Enterobacteriaceae M7-MIC, table 3: Nonfastidious Quality Control. M7-MIC, volume 28(1). Wayne, PA.
13. [CLSI] Clinical and Laboratory Standards Institute. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, eight edition: Approved Standard; 26. M07-A8. Wayne, PA.
14. [CLSI] Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement; 28. M100-S19. Wayne, PA.
15. [DANMAP] Danish Integrated Antimicrobial Resistance Monitoring and Research Programme. 2006. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Available at www.danmap.org/pdfFiles/Danmap- 2006.pdf, accessed 6 January 2011. (Online.)
16. [DANMAP] Danish Integrated Antimicrobial Resistance Monitoring and Research Programme. 2009. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Available at www.danmap.org/pdfFiles/Danmap- 2009.pdf. accessed 6 January 2011. (Online.)
17. Dias, R.C.S., D.V. Marangoni, S.P. Smith, E.M. Alves, F.L.P.C. Pellegrino, L.W. Riley, and B.M. Moreira. 2009. Clonal Composition of Escherichia coli causing communityacquired urinary tract infections in the State of Rio de Janeiro, Brazil. Microb. Drug Resist. 15:303-308.
18. Everett, M.J., Y.F. Jin, V. Ricci, and L.V. Piddock. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386. (Pubitemid 26328050)
19. Fendukly, F., I. Karlson, H.S. Hanson, G. Kronvall, and K. Dornbusch. 2003. Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin. APMIS 111:857-866. (Pubitemid 37222730)
20. Frimodt-Møller, N. 2006. Urinvejsinfektioner. In K. Kjeldsen, L.P. Nielsen, N.A. Peterslund et al. Infektionssygdomme og mikrobiologi. Akademisk forlag, København, pp. 107- 119. (In Danish language.)
21. Hansen, W., and E. Yourassowsky. 1984. Detection of 3-glucuronidase in lactose-fermenting members of the family enterobacteriaceae and its presence in bacterial urine cultures. J. Clin. Microbiol. 20:1177-1179. (Pubitemid 15219328)
22. Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49:801-803. (Pubitemid 40175702)
23. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
24. Hopkins, K.L., R.H. Davies, and E.J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int. J. Antimicrob. Agents 25:358-373. (Pubitemid 40558766)
25. Invitrogen. TA Cloning Kit Version V 7 April 2004. Available at http://tools.invitrogen.com/content/sfs/manuals/ ta-man.pdf, accessed 6 January 2011. (Online.)
26. Jacoby, G.A. 2005. Mechanisms of Resistance to Quinolones. Clin. Infect. Dis. 41:120-126.
27. Jacoby, G.A., N. Chow, and K.B. Waites. 2003. Prevalence of plasmid-mediated quinolone resistance. Antimicrob. Agents Chemother. 47:559-562. (Pubitemid 36158082)
28. Jakobsen, L., D. Sandvang, L.H. Hansen, L. Bagger-Skjøt, H. Westh, C. Jørgensen, D.S. Hansen, B.M. Pedersen, D.L. Monnet, N. Frimodt-Møller, S.J. Sørensen, and A.M. Hammerum. 2008. Characterisation, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment. Environ. Int. 34:108-115. (Pubitemid 350235607)
29. Jensen, U.S., A. Muller, C.T. Brandt, N. Frimodt-Møller, A.M. Hammerum, and D.L. Monnet; DANRES Study Group. 2010. Effect of generics on price and consumption of ciprofloxacin in primary healthcare: The relationship to increasing resistance. J. Antimicrob. Chemother. 65:1286-1291.
30. Jeong, J., E.S. Kim, S. Choi, H. Kwon, S. Lee, S. Lee, M. Kim, J.H. Woo, and Y.S. Kim. 2005. Effects of a plasmidencoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes. Diagn. Microbiol. Infect. Dis. 60:105-107. (Pubitemid 350235168)
31. Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
32. Kern, W.V., P. Steinke, A. Schumacher, S. Schuster, H. von Baum, and J.A. Bohnert. 2005. Effect of 1-(1-naphthylmethyl)- piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343. (Pubitemid 43160180)
33. Kilian, M., and P. Bülow. 1976. Rapid diagnosis of Enterobacteriaceae. I. Detection of bacterial glycosidases. APMIS Section B 84:245-251.
34. Lindgren, P.K., A. Karlsson, and D. Hughes. 2003. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 47:3222-3232. (Pubitemid 37229582)
35. Machado E., T.M. Coque, R. Cantón, F. Baquero, J.C. Sousa, and L. Peixe. 2006. Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob. Agents Chemother. 50:3220-3221. (Pubitemid 44396445)
36. Manges A.R., J.R. Johnson, B. Foxman, T.T. O'bryan, K.E. Fullerton, and L.W. Riley. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345:1007-1013.
37. Martínez-Martínez, L., A. Pascual, and G.A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799. (Pubitemid 28112342)
38. Moon D.C., S.Y. Seol, M. Gurung, J.S. Jin, C.H. Choi, J. Kim, Y.C. Lee, D.T. Cho, and J.C. Lee. 2009. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int. J. Antimicrob. Agents. 35:76-79.
39. Morgan-Linell, S.K., and L. Zechiedrich. 2007. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 51:4205-4208. (Pubitemid 350057831)
40. Okusu, H., and D. Ma. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J. Bacteriol. 178:306-308. (Pubitemid 26006095)
41. Pagés, J., M. Masi, and J. Barbe. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11:382-389. (Pubitemid 41080580)
42. Pannek, S., P.G. Higgins, P. Steinke, D. Jonas, M. Akova, J.A. Bohnert, H. Seifert, and W.V. Kern. 2006. Multidrug efflux inhibition in Acinetobacter baumannii: Comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginineb- naphthylamide. J. Antimicrob. Chemother. 57:970-974.
43. Park, C.H., A. Robicsek, G.A. Jacoby, D. Sahm, and D.C. Hooper. 2006. Prevalence in the United States of aac(6)-Ib-cr encoding a ciprofloxacin- modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955. (Pubitemid 44684926)
44. Perichon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469. (Pubitemid 47047325)
45. Petersen, A., J.P. Christensen, P. Kuhnert, M. Bisgaard, and J.E. Olsen. 2006. Vertical transmission of a fluoroquinolone- resistant Escherichia coli within an integrated broiler operation. Vet. Microbiol. 116:120-128. (Pubitemid 44108498)
46. Ribot E.M., M.A. Fair, R. Gautom, D.N. Cameron, S.B. Hunter, B. Swaminathan, and T.J. Barrett. 2006. Standardization of pulse-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-72.
47. Robicsek, A., G.A. Jacoby, and D.C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640. (Pubitemid 44427732)
48. Robicsek, A., J. Strahilevitz, G.A. Jacoby, M. Macielag, D. Abbanat, C.H. Park, K. Bush, and D.C. Hooper. 2006. Fluoroquinolone- modifying enzyme: A newadaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88. (Pubitemid 43050081)
49. Sáenz, Y., J. Ruiz, M. Zarazaga, M. Teixidó, C. Torres, and J. Vila. 2004. Effect of the efflux pump inhibitor Phe-Arg-bnaphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545. (Pubitemid 38380260)
50. Shen, P., Y. Jiang, Z. Zhou, J. Zhang, Y. Yu, and L. Li. 2008. Complete nucleotide sequence of pKP96, a 67 850 bp multiresistance plasmid encoding qnrA1, aac(6')-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 62:1252-1256.
51. Sorlozano, A., J. Gutierrez, A. Jimenez, J. de Dios Luna, and J.L. Martínez. 2007. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-lactamaseproducing Escherichia coli isolates. J. Clin. Microbiol. 45: 2740-2742. (Pubitemid 47295520)
52. Swanberg, S.L., and J.C. Wang. 1987. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J. Mol. Biol. 197:729-736.
53. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
54. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 1.1 April 2010. Available at www.eucast.org/fileadmin/src/media/PDFs/EUCAST- files/Disk-test-documents/EUCAST-breakpoints-v1.1.pdf. accessed 6 January 2011. (Online.)
55. Tran, J.H., and G.A. Jacoby. 2002. Mechanism of plasmidmediated quinolone resistance. Proc. Natl. Acad. Sci. U. S. A. 99:5638-5642.
56. Valentine, S.C., D. Contreras, S. Tan, L.J. Real, S. Chu, and H.H. Xu. 2008. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J. Clin. Microbiol. 46:2499-2507.
57. Vliegenthart, J.S., P.A.G. Ketelaar-Van Gaalen, and J.A.M. Van de Klundert. 1991. Nucleotide sequence of the aacC3 gene, a gentamicin resistance determinant encoding aminoglycoside-( 3)-N-acetyltransferase III expressed in Pseudomonas aeruginosa but not in Escherichia coli. Antimicrob. Agents Chemother. 35:892-897.
58. Wang, M., Q. Guo, X. Xu, X. Wang, X. Ye, S. Wu, D.C. Hooper, and M. Wang. 2009. New plasmid-mediated quino- lone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 53:1892-1897.
59. Wei, Q., X. Jiang, Z. Yang, N. Chen, X. Chen, G. Li, and Y. Lu. 2009. dfrA27, a new integron-associated trimethoprim resistance gene from Escherichia coli. J. Antimicrob. Chemother. 63:405-406.
60. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA Gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272. (Pubitemid 20177394)